ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
SSGA SPDR ETFs Europe II PLC MSCI Europe Utilities UCITs ETF (PK)

SSGA SPDR ETFs Europe II PLC MSCI Europe Utilities UCITs ETF (PK) (SSMEF)

0.00
0.00
( 0.00% )

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

SSMEF Latest News

Vyome to go public and trade on the Nasdaq Capital Market under the ticker symbol “HIND”

CAMBRIDGE, Mass., July 09, 2024 (GLOBE NEWSWIRE) -- Vyome Therapeutics, a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with...

ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys

ReShape and Vyome, a Clinical Stage Specialty Pharmaceutical Company Working To Treat Immuno-Inflammatory Diseases of Unmet Need, to Combine in All-Stock Merger ReShape to Sell its Assets to...

ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update

Commercial Launch of Next-Generation Lap-Band® 2.0 FLEX Continues Significant Reduction in Overall Operating Expenses of 51% in the First Quarter of 2024 Compared to the First Quarter of 2023...

ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update

IRVINE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it...

ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update

Completed First Surgeries With Next-Generation Lap-Band® 2.0 FLEX 2024 Operating Expenses Expected to Decrease by more than 50% Compared to 2023; Reaffirming Commitment to Profitability...

ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System

IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NCNCnoco noco Inc
$ 0.2701
(76.54%)
274.07M
NUZENuZee Inc
$ 6.14
(65.95%)
34.9M
MOLNMolecular Partners AG
$ 9.71
(52.31%)
78.11k
PMECPrimech Holdings Ltd
$ 0.7461
(41.79%)
94.71M
LSHLakeside Holding Ltd
$ 3.3306
(40.53%)
25.08M
CETUCetus Capital Acquisition Corporation
$ 2.2493
(-61.68%)
114.57k
CETUUCetus Capital Acquisition Corporation
$ 2.80
(-60.00%)
1.92k
IMNNImunon Inc
$ 1.41
(-57.53%)
13.82M
FGENFibroGen Inc
$ 0.5275
(-48.79%)
13.85M
PEPGPepGen Inc
$ 10.5725
(-37.74%)
1.18M
NVDANVIDIA Corporation
$ 115.74
(11.58%)
299.62M
NCNCnoco noco Inc
$ 0.2701
(76.54%)
274.08M
PRSTPresto Technologies Inc
$ 0.039549
(13.00%)
187.94M
SQQQProShares UltraPro Short QQQ
$ 8.6613
(-8.15%)
161.82M
FFIEFaraday Future Intelligent Electric Inc
$ 0.3515
(11.23%)
133.78M

Discussion

View Full Feed
m$teamworkotc m$teamworkotc 2 minutes ago
$VXIT--volume coming in 0015 thin AF to 002s
expecting updates by friday
https://x.com/OfficialVXIT/status/1816835322921062643……
VXIT
Tiger Money Tiger Money 2 minutes ago
The FDA is corrupt and has blood on her hands. Covid proved my statement. FDA rejected or remained silent on all therapeutics. That is a fact. Call it what you want.
RDGL
getmoreshares getmoreshares 3 minutes ago
FINALLY - some VOL!
AIKO
DrHigh DrHigh 3 minutes ago
He is a masterful pumper. My mother in law installed a new reverse osmosis water filtration system in her house and DStock wrote a 400 word primer on how it is a bullish sign that we will see MHRA approval in August. It was beautiful.
NWBO
GigantorX GigantorX 3 minutes ago
BM can't be trusted, that we know. The numbers are the numbers....no profit, more debt, more sketchy share selling schemes and more broken promises.

As you said, plan for the pump and get out at the top.
IQST
S-BEES-BUMBLEBEE S-BEES-BUMBLEBEE 3 minutes ago
Did ya sell already? :-D
TANH
Spuds McKenz66 Spuds McKenz66 3 minutes ago
Bids are strong building @191 CLOV
CLOV
BCCHoosier BCCHoosier 3 minutes ago
This new and very comprehensive report is very well done. All should read. Thanks for sharing.
AVXL
Mark Mark 3 minutes ago
$BBLG 2.35 worth watching
BBLG
S-BEES-BUMBLEBEE S-BEES-BUMBLEBEE 3 minutes ago
Thinking of cancelling bids and starting to slap dat fkn ask...
TANH
Brickwall10 Brickwall10 4 minutes ago
Honestly still trying to figure out this company. Does share reduction and hires company for audit for uplist. But then can’t get a website up and running? Maybe there is something bigger in the works behind the scenes? I dunno
GRLF
jedijazz jedijazz 4 minutes ago
$OCTO (Nasdaq) Press -Latest video update
https://cutt.ly/vehrFyHA $BCA $WFC
BCA OCTO WFC
johnydollar johnydollar 4 minutes ago
That's what she said........

I wonder how many phone calls Linda and the attorney got to take revocation.......

If any ,were this anonymous 🤔.........

Phone records can resolve that very quickly.......

I have not seen a payphone for
DBMM
jedijazz jedijazz 4 minutes ago
$OCTO (Nasdaq) Press -Latest video update
https://cutt.ly/vehrFyHA $BCA $WFC
BCA OCTO WFC
packerfan9 packerfan9 4 minutes ago
The printing press is working 24/7 printing new shares to sell to suckers. They will never sell enough cbd to justify the billions in new dilution going on. Same as past dulition. Anyone buying is a sucker as it will be at .0001. Buys are being filled by new shares sold. Same as before the r/s's. If
CBDL
Tomorrowneverknows Tomorrowneverknows 4 minutes ago
Nice professional
HIRU
Tiger Money Tiger Money 5 minutes ago
Me too and agreed
AGBA
jrsh jrsh 5 minutes ago
There is clearly a tough CEO missing who kicks a##es if they continuesly announce stuff and than... NOTHING!!!

It seems very much to me that they miss guidance and accountability and are unable to work against a target like they would have to do in a real world company!!!
NSAV
HigherStandard HigherStandard 5 minutes ago
LOL!...If you already own 15 million or so; why don't you sell and knock it down to the trips....
GGSM
MN Gopher MN Gopher 5 minutes ago
Good info GMH, So Iova max will be 10,000
Patients, Not 12,000.

WuXi in the USA has a max of 5,000.

15,000 infusions pr year would be massive, not including any overseas infusions.

The IP transfer sounds possible like you stated, issues wise.
IOVA
StonkMaster StonkMaster 5 minutes ago
Like everything he posts, nothing.

:)
NWBO
biotechinvestor1 biotechinvestor1 5 minutes ago
Market participants are expecting good news on the deal front. Helen mentioned in May that halo has completed the ‘technical’ phase of a new partnership. The next phase is legal which should not take more than a few months.

If the new deal is a HVAI, there will be a sustained upward t
HALO
StayHumble StayHumble 5 minutes ago
10km00t🟩8km00t🟩ALJm00t 47Wins
JudgeFAV0RED$DBMM. Meaning the ruling? +1

Source: https://www.sec.gov/alj/aljdec/2019/id1389cff.pdf
No available sanction appropriate|Thus Proceeding Dismissed.
-------------------------------V. ORDER--------
DBMM